Our Innovation With 10% of its revenue (at December 31, 2020) and a dedicated headcount of 200 across 4 centers (France, Israel and USA), significant resources are devoted to innovation. Guerbet’s research ambition is to offer radiology professionals and patients safe and innovative solutions, whether drugs or medical devices (including “software” solutions), that meet their needs. Guerbet’s work is focused on two medical imaging segments: Diagnostic Imaging and Interventional Imaging. *at December 31, 2020 Homepage Our Group Our Innovation Solutions for the Future Guerbet’s research ambition is to offer radiology professionals and patients safe and innovative solutions, whether drugs or medical devices (including “software” solutions), that meet their needs. Guerbet’s work is focused on two medical imaging segments: Diagnostic Imaging and Interventional Imaging. The two radiology activities, Diagnostic Imaging and Interventional Imaging, are researched in the three main therapeutic areas of . Show More Research and Development portfolio Guerbet is stepping up its investments in diagnostic imaging, particularly with two phase III clinical studies related to gadopiclenol in MRI, and in interventional imaging with increased research relating to the microcatheter range following the acquisition of Accurate Medical. With regard to Delivery Systems and Services, the Research and Development engineers are currently focusing on three strategic areas: connecting injectors to imaging equipment; developing solutions for the tracing of injected doses; and ensuring the safety of medical procedures through innovative devices. Show More Scientific partnerships worldwide The success of Guerbet’s R&D is based on successful collaboration with worldwide scientific partners. Medical imaging is a multi-disciplinary field requiring expertise in chemistry, physics, computing, image processing, electronics, biology and medicine. Several collaborative research programs are being conducted. The largest of these is the Iseult project, financed by Bpifrance (a public investment bank formerly known as Oséo Innovation). The goal of this project, conducted in collaboration with the Neurospin center of the Atomic Energy Commission (CEA), is to make progress in MRI by using very high magnetic fields. The expected benefit of these new technologies is improved sensitivity in the detection of small brain lesions that cannot be detected using standard techniques. Show More Become a partner First name * Last name * E-mail * Country of residence * Your profession * Your project * Captcha ERROR: ReCaptcha v.2 is missing the Site Key - Please update the web.config to include 'key="RecaptchaSiteKey"' Your personal data Your personal data will be processed by Guerbet in order to contact you. You are informed that Guerbet may use, reproduce, publish, modify, or transmit the information you provide to us with the aim of processing your request. The legal basis for the processing of your personal data is your consent (voluntary registration on the contact form). Your personal data will be stored until signing out using the sign-off link at the bottom of the email. They may be processed by authorized third parties on behalf of Guerbet solely for the purpose of processing your request. You have the right to revoke your consent at any time by signing out using the sign-off link at the bottom of the emails. You have the right to request access to and rectification or erasure of your personal data, or the restriction of processing, by contacting the controller via email at dataprotection.officer@guerbet.com You have the right to lodge a complaint with the national authority for data protection if you consider that any of your personal data are processed in breach of the applicable law. Media Legal Information Universal Registration Document Patents Contact Copyright © Guerbet 2021 LinkedIn Twitter Instagram YouTube Cookie disclaimer Guerbet uses cookies to improve your experience and to analyze traffic patterns of visitors. By continuing your visit on this website without changing your settings, you consent to the use of cookies in accordance with our Cookie Policy. Find out more OK